MK-2870 Monotherapy or in combination with other anticancer agents in Gastrointestinal cancers

A Phase 1/2 Substudy of the MK-9999-U02 Master Protocol to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers

Disease Types: Cholangiocarcinoma

Available at: Alleghany, Blacksburg, Roanoke, Salem, Wytheville

A Phase 1/2 Substudy of the MK-9999-U02 Master Protocol to Evaluate the Safety and Efficacy of MK-2870 Monotherapy or in Combination With Other Anticancer Agents in Gastrointestinal Cancers

For More Information:

https://clinicaltrials.gov/study/NCT06428409?term=%20MK-2870%20Monotherapy%20or%20in%20Combination%20With%20Other%20Anticancer%20Agents%20in%20Gastrointestinal%20Cancers&rank=1